Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.
Belgodère L, Emmerich J, Albin N, Bacon T, Daynes P, Vignot S, Vial T, Renaud G, Le Saulnier C, Maillard-Couvreur C, Cachet M, Veyries ML, Youdarene R, Oualikene-Gonin W, Ratignier-Carbonneil C, Maison P. Belgodère L, et al. Front Public Health. 2023 Nov 17;11:1293110. doi: 10.3389/fpubh.2023.1293110. eCollection 2023. Front Public Health. 2023. PMID: 38045969 Free PMC article.
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products.
Oualikene-Gonin W, Sautou V, Ezan E, Bastos H, Bellissant E, Belgodère L, Maison P, Ankri J; Scientific Advisory Board of the ANSM. Oualikene-Gonin W, et al. Among authors: belgodere l. Front Public Health. 2023 Mar 2;11:1125577. doi: 10.3389/fpubh.2023.1125577. eCollection 2023. Front Public Health. 2023. PMID: 36935690 Free PMC article.
Patient and public involvement in the benefit-risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM).
Belgodère L, Pougheon Bertrand D, Jaulent MC, Rabeharisoa V, Janssens W, Rollason V, Barbot J, Vernant JP, Oualikene Gonin W, Maison P, Ankri J; Scientific Advisory Board of the ANSM. Belgodère L, et al. BMJ Glob Health. 2023 May;8(5):e011966. doi: 10.1136/bmjgh-2023-011966. BMJ Glob Health. 2023. PMID: 37208125 Free PMC article. No abstract available.
Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity.
Lapière J, Christen C, Kerouani-Lafaye G, Monard A, Turcry F, Grude F, Gazin V, Burbank M, Chocarne P, Taleb A, Belgodere L, Brunel L, Chu C, Deligny C, Ake E, Gonçalves S, Bouheret P, Barbou-des-Courières S, Sainte-Marie I, Guyader G, Boudali L, Albin N. Lapière J, et al. Among authors: belgodere l. Ther Innov Regul Sci. 2021 May;55(3):601-611. doi: 10.1007/s43441-020-00256-7. Epub 2021 Jan 27. Ther Innov Regul Sci. 2021. PMID: 33502745
Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities.
Oualikene-Gonin W, Jaulent MC, Thierry JP, Oliveira-Martins S, Belgodère L, Maison P, Ankri J; Scientific Advisory Board of ANSM. Oualikene-Gonin W, et al. Among authors: belgodere l. Front Pharmacol. 2024 Aug 2;15:1437167. doi: 10.3389/fphar.2024.1437167. eCollection 2024. Front Pharmacol. 2024. PMID: 39156111 Free PMC article.